Log in to search using one of your social media accounts:

 

Quick Test Could Spot Precursor to Esophageal Cancer
(Source: Cancercompass News: Other Cancer)
Source: Cancercompass News: Other Cancer - January 20, 2018 Category: Cancer & Oncology Source Type: news

Quick Test Could Spot Precursor to Esophageal Cancer
FRIDAY, Jan. 19, 2018 -- A pill-sized device that you swallow might help detect a change in the esophagus that can lead to a deadly form of cancer, researchers are reporting. The esophagus is the tube that carries food from your mouth to your... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - January 19, 2018 Category: General Medicine Source Type: news

Robotic Surgery Scores in Esophageal Cancer Study
(MedPage Today) -- Fewer complications, same disease control as open surgery in trial (Source: MedPage Today Gastroenterology)
Source: MedPage Today Gastroenterology - January 19, 2018 Category: Gastroenterology Source Type: news

Can mice really mirror humans when it comes to cancer?
(Michigan State University) A new Michigan State University study is helping to answer a pressing question among scientists of just how close mice are to people when it comes to researching cancer. The findings reveal how mice can actually mimic human breast cancer tissue and its genes, even more so than previously thought, as well as other cancers including lung, oral and esophagus. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - January 18, 2018 Category: Cancer & Oncology Source Type: news

Researchers develop swallowable test to detect pre-cancerous Barrett's esophagus
(Case Western Reserve University) Investigators at Case Western Reserve University School of Medicine and University Hospitals Cleveland Medical Center have developed a simple, swallowable test for early detection of Barrett's esophagus that offers promise for preventing deaths from esophageal adenocarcinoma. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - January 17, 2018 Category: Cancer & Oncology Source Type: news

Pembrolizumab Promising in Advanced Esophageal Cancer (CME/CE)
(MedPage Today) -- 30% of PD-L1-positive patients achieve partial response in small study (Source: MedPage Today Gastroenterology)
Source: MedPage Today Gastroenterology - January 7, 2018 Category: Gastroenterology Source Type: news

Predicting Prognosis in Submucosal Invasive Esophageal SCC Predicting Prognosis in Submucosal Invasive Esophageal SCC
This study sought to identify histopathological characteristics that could predict lymph node metastasis in submucosal invasive esophageal squamous cell carcinoma.American Journal of Clinical Pathology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 3, 2018 Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news

RT Without Chemo for Dysphagia in Advanced Esophageal Cancer RT Without Chemo for Dysphagia in Advanced Esophageal Cancer
Palliative radiotherapy is slightly less effective but much less toxic than palliative chemoradiotherapy for dysphagia in patients with advanced esophageal cancer, according to results from a randomized trial.Reuters Health Information (Source: Medscape Radiology Headlines)
Source: Medscape Radiology Headlines - December 27, 2017 Category: Radiology Tags: Hematology-Oncology News Source Type: news

Studies Link Oral Microbiome to Cancers (CME/CE)
(MedPage Today) -- Higher risk of esophageal, gastric cancers (Source: MedPage Today Gastroenterology)
Source: MedPage Today Gastroenterology - December 22, 2017 Category: Gastroenterology Source Type: news

National Oesophago-Gastric Cancer Audit Report 2017
This 2017 annual report provides the most up-to-date information on the care and outcomes of patients diagnosed with OG cancer or oesophageal high grade dysplasia. The information is primarily published to support the quality improvement activities in hospitals providing OG cancer care as well as the commissioners of cancer services. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - December 21, 2017 Category: Consumer Health News Source Type: news

7 medtech stories we missed this week: Dec. 8, 2017
[Image from unsplash.com]From Minimus Spine’s European distribution deal to Stimwave receiving FDA clearance, here are seven medtech stories we missed this week but thought were still worth mentioning. 1. Minimus Spine inks EU distribution deal Minimus Spine announced in a Dec. 4 press release that it has signed its first European distribution deal with Italian company Moss and has completed its first commercial order. Moss has exclusive distribution rights to distribute in Italy, Germany, Switzerland and the U.K. 2. Elanix, Dermacon sign wound management development deal Elanix Biotechnologies and Dermacon...
Source: Mass Device - December 8, 2017 Category: Medical Devices Authors: Danielle Kirsh Tags: 510(k) Cardiac Assist Devices Cardiovascular Diagnostics Food & Drug Administration (FDA) Hospital Care Pain Management Regulatory/Compliance Cagent Vascular CSA Medical Inc. Dermacon Elanix Life Spine Inc. MedTech Minimus Spin Source Type: news

Some Oral Bacteria Tied to Esophageal Cancer Risk Some Oral Bacteria Tied to Esophageal Cancer Risk
Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - December 6, 2017 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Nigeria:Gum Disease Tied to Cancer, Others
[Guardian] Add one more reason to why you should brush and floss regularly: Gum disease bacteria are now tied to higher odds of oesophageal cancer. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - December 6, 2017 Category: African Health Source Type: news

UH cancer researcher focused on tumor development
(University of Houston) A University of Houston researcher has received a $900,000 grant from the National Cancer Institute to deliver an unprecedented look at development of esophageal cancer. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - December 6, 2017 Category: Cancer & Oncology Source Type: news

Gum Disease Tied to Yet Another Deadly Illness
Add one more reason to why you should brush and floss regularly: Gum disease bacteria are now tied to higher odds of esophageal cancer. (Source: WebMD Health)
Source: WebMD Health - December 1, 2017 Category: Consumer Health News Source Type: news

Gum Disease Tied to Yet Another Deadly Illness
Source: HealthDay Related MedlinePlus Pages: Dental Health, Esophageal Cancer, Gum Disease (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - December 1, 2017 Category: Consumer Health News Source Type: news

Medical News Today: Mouth bacteria linked to esophageal cancer
New research reveals that some types of mouth bacteria are linked to higher risk of developing esophageal cancer and some are linked to lower risk. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - December 1, 2017 Category: Consumer Health News Tags: Cancer / Oncology Source Type: news

Gum Disease Tied to Yet Another Deadly Illness
FRIDAY, Dec. 1, 2017 -- Add one more reason to why you should brush and floss regularly: Gum disease bacteria are now tied to higher odds of esophageal cancer. The study tracked the oral health of 122,000 Americans for 10 years. It found that the... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - December 1, 2017 Category: General Medicine Source Type: news

Oral microbiota indicates link between periodontal disease and esophageal cancer
(American Association for Cancer Research) An analysis of bacteria present in the mouth showed that some types of bacteria that lead to periodontal disease were associated with higher risk of esophageal cancer. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - December 1, 2017 Category: International Medicine & Public Health Source Type: news

Researchers ID bacteria tied to esophageal cancer
(NYU Langone Health / NYU School of Medicine) Researchers at NYU Langone Health's Perlmutter Cancer Center report that at least three kinds of bacteria in the mouths of Americans may heighten or lower their risk of developing esophageal cancer. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - December 1, 2017 Category: International Medicine & Public Health Source Type: news

Video: Radiofrequency ablation of the esophagus
Radiofrequency ablation uses high-frequency radio waves to treat Barrett's esophagus and esophageal cancer. (Source: MayoClinic.com Full Feed)
Source: MayoClinic.com Full Feed - November 30, 2017 Category: Consumer Health News Source Type: news

Esophagectomy
is surgery to remove your esophagus. It's used to treat Barrett's esophagus and esophageal cancer. (Source: MayoClinic.com Full Feed)
Source: MayoClinic.com Full Feed - November 29, 2017 Category: Consumer Health News Source Type: news

Endoscopy Could Spare More Barrett's Patients From Surgery Endoscopy Could Spare More Barrett's Patients From Surgery
For patients with Barrett's esophagus, endoscopy, a recognized treatment for high-grade dysplasia, is just as effective for intramucosal carcinoma, new research shows.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 17, 2017 Category: Consumer Health News Tags: Gastroenterology News Source Type: news

Wider sampling of tumor tissues may guide drug choice, improve outcomes
This study challenges current guidelines and supports evaluation of metastatic lesions and circulating tumor DNA. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - November 15, 2017 Category: Cancer & Oncology Source Type: news

Cancer Doctors Cite Risks of Drinking Alcohol
Drinking alcohol, even modest amounts, increases the risk of breast cancer and other cancers. (Source: NYT Health)
Source: NYT Health - November 7, 2017 Category: Consumer Health News Authors: RONI CARYN RABIN Tags: Head and Neck Cancer Breast Cancer Esophageal Cancer Mouth Colon and Colorectal Cancer Liver Cancer Alcoholic Beverages Alcohol Abuse Advertising and Marketing Source Type: news

Long-term use of PPIs linked to doubling in stomach cancer risk
Risk rose with dose and duration of treatment after H pylori eradication Related items fromOnMedica Proton pump inhibitors associated with raised mortality Oesophageal and stomach cancer linked to early adulthood overweight Experts link alcohol to stomach cancer (Source: OnMedica Latest News)
Source: OnMedica Latest News - November 1, 2017 Category: UK Health Source Type: news

Aspirin 'cuts risk of cancer by up to half'
A trial involving more than half a million people found long-term aspirin users cut their risk of liver and oesophageal cancer by almost half, while their odds of getting bowel cancer fell by a quarter. (Source: the Mail online | Health)
Source: the Mail online | Health - October 31, 2017 Category: Consumer Health News Source Type: news

Long-term aspirin use reduces the incidence of digestive cancers by up to 47 percent
(Spink Health) In a study involving over 600,000 people, those prescribed with aspirin showed a 47 percent reduction in liver and esophageal cancer incidence, a 38 percent reduction in gastric cancer incidence, a 34 percent reduction in pancreatic cancer incidence and a 24 percent reduction in colorectal cancer incidence. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - October 30, 2017 Category: Cancer & Oncology Source Type: news

Proton therapy may be better option for elderly patients with esophageal cancer
(Mayo Clinic) A study led by Mayo Clinic researchers has found that proton beam therapy, in combination with chemotherapy, prior to surgery, may be a better option than a combination using traditional radiation therapy techniques with chemotherapy when treating elderly patients with esophageal cancer. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - October 24, 2017 Category: Cancer & Oncology Source Type: news

Proton therapy may be better option for elderly patients with esophageal cancer
CHICAGO ? A study led by Mayo Clinic researchers has found that proton beam therapy, in combination with chemotherapy, prior to surgery, may be a better option than a combination using traditional radiation therapy techniques with chemotherapy when treating elderly patients with esophageal cancer. Standard X-ray radiation therapy techniques include 3-D conformal radiation and intensity-modulated [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - October 24, 2017 Category: Databases & Libraries Source Type: news

Electronic Nose Promising for Barrett's Esophagus Detection
(MedPage Today) -- Test may facilitate surveillance for esophageal adenocarcinoma (Source: MedPage Today Gastroenterology)
Source: MedPage Today Gastroenterology - October 17, 2017 Category: Gastroenterology Source Type: news

Esophageal cancer 'cell of origin' identified
(Columbia University Medical Center) Researchers at Columbia University Medical Center have identified cells in the upper digestive tract that can give rise to Barrett's esophagus, a precursor to esophageal cancer. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - October 11, 2017 Category: Cancer & Oncology Source Type: news

Zinc supplements found to protect against esophageal cancer
(Natural News) A new study finds that zinc supplements can help prevent cancer in the esophagus, as reported by Science Daily. Researchers at the University of Texas at Arlington (UTA) evaluated the reaction of human esophageal cancer cells and healthy human cells to zinc. They discovered that zinc supplements slowed down the growth of esophageal cancer... (Source: NaturalNews.com)
Source: NaturalNews.com - October 8, 2017 Category: Consumer Health News Source Type: news

New studies add to understanding of treatments for Barrett's esophagus
(American Society for Gastrointestinal Endoscopy) The October issue of GIE: Gastrointestinal Endoscopy features several new studies evaluating various treatments for Barrett's esophagus (BE). BE is a condition in which there are unusual changes to the cells lining the esophagus. It is believed to be most commonly due to inflammation from gastroesophageal reflux disease (GERD). Sometimes these changes may be considered precancerous. Endoscopic treatments for BE focus on removing or destroying the problematic tissue. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - October 6, 2017 Category: Cancer & Oncology Source Type: news

First patient treated with CSA Medical ’ s AV spray catheter
CSA Medical said today that the first patient was treated using the company’s new rapid AV spray catheter for the management of persistent symptomatic esophageal cancer and associated dysplastic Barrett’s disease. The device uses a stainless steel catheter wall to cut the time needed to deliver liquid nitrogen spray to the treatment site by 50%, the company said. It was recently cleared for use with CSA Medical’s truFreeze system – a cryosurgical tool used to ablate benign and malignant lesions. Get the full story at our sister site, Drug Delivery Business News. The post First patient treated w...
Source: Mass Device - October 3, 2017 Category: Medical Devices Authors: Sarah Faulkner Tags: Drug-Device Combinations Oncology Surgical CSA Medical Inc. Source Type: news

Medical News Today: Zinc may help to prevent, treat esophageal cancer
Zinc can halt the growth of esophageal cancer cells by inhibiting overactive calcium signaling, according to the results of a new study. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - September 29, 2017 Category: Consumer Health News Tags: Cancer / Oncology Source Type: news

Cancer breakthrough: Taking THIS supplement could halt growth of deadly cells
CANCER of the oesophagus is a deadly condition, with symptoms including indigestion and difficulty swallowing. But taking a regular zinc supplement could stop cancerous cells in their tracks. (Source: Daily Express - Health)
Source: Daily Express - Health - September 29, 2017 Category: Consumer Health News Source Type: news

UTA study says zinc can halt the growth of cancer cells
(University of Texas at Arlington) Zinc supplements can significantly inhibit the proliferation of esophageal cancer cells, according to a new study co-authored by a University of Texas at Arlington researcher. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - September 28, 2017 Category: Cancer & Oncology Source Type: news

Cernostics Announces Leadership Team Expansion
New Commercial Leader Positions Company for Continued Success and Growth BETHLEHEM and PITTSBURGH, Pa., Sept. 12, 2017 -- (Healthcare Sales & Marketing Network) -- Cernostics, a privately-held diagnostics company focused on delivering next-generation c... Diagnostics, Oncology, Personnel Cernostics, TissueCypher, Barrett's Esophagus, esophageal cancer (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 12, 2017 Category: Pharmaceuticals Source Type: news

Drinks industry accused of downplaying 'alcohol-cancer risk'
Conclusion This qualitative analysis aimed to determine the accuracy of health information circulated by the alcohol industry on the links between alcohol and cancer. It found the industry and affiliated organisations use three main approaches: denial of the link between alcohol and cancer misinterpretation of the risk distraction by focusing on other risk factors This analysis highlights how these strategies could be detrimental to public health. Of course, it's possible, given this data was collected in 2016, that some of the websites and documents analysed by the researchers have since been updated. Regardless, the...
Source: NHS News Feed - September 8, 2017 Category: Consumer Health News Tags: Cancer Source Type: news

MIRO: Minimally Invasive Surgery for Esophageal Cancer MIRO: Minimally Invasive Surgery for Esophageal Cancer
Patients with resectable esophageal cancer should undergo hybrid minimally invasive surgery, urge experts after a trial showed it markedly reduce postoperative morbidity vs open surgery.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - September 8, 2017 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Consider plant-based diet for treating reflux symptoms
PPIs no better than plant-based Mediterranean diet plus alkaline water at improving LPR symptoms, research suggests Related items fromOnMedica Oesophageal and stomach cancer linked to early adulthood overweight Plant protein consumption linked to increased longevity Plant-based diet not always best for heart health (Source: OnMedica Latest News)
Source: OnMedica Latest News - September 8, 2017 Category: UK Health Source Type: news

MIRO trial: 3-year outcomes favor laparoscopic surgery for esophageal cancer
(European Society for Medical Oncology) Patients requiring surgery for esophageal cancer fare better after undergoing a hybrid minimally invasive esophagectomy compared to an open esophagectomy, according to long-term results of the MIRO trial to be presented at the ESMO 2017 Congress in Madrid. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - September 4, 2017 Category: Cancer & Oncology Source Type: news

CSA Medical wins another FDA expansion for TruFreeze cryotherapy
Endoscopic cryo-ablation company CSA Medical said today it won expanded FDA 510(k) clearance for its TruFreeze spray cryotherapy system, now cleared for use on patients with Barrett’s esophagus with low grade dysplasia. With the clearance, the device is now approved for both low and high grade dysplasia as well as malignancies, the Boston-based company said. “Over the past few years, studies have underscored the potential risk for Barrett’s esophagus with low grade dysplasia to progress to esophageal adenocarcinoma. Intervening at this level of dysplasia has become common practice and is recogni...
Source: Mass Device - August 31, 2017 Category: Medical Devices Authors: Fink Densford Tags: 510(k) Food & Drug Administration (FDA) Otolaryngology Ear, Nose & Throat Regulatory/Compliance CSA Medical Inc. Source Type: news

CSA Medical Announces Expansion of truFreeze(R) Label to Include Barrett's Esophagus with Low Grade Dysplasia
From Barrett's Esophagus to Malignancy - Only truFreeze® BOSTON, Aug. 31, 2017 -- (Healthcare Sales & Marketing Network) -- CSA Medical announced on Thursday, the expansion of its truFreeze® label with the addition of Barrett's Esophagus with l... Devices, Interventional, FDA CSA Medical, truFreeze, Barrett's Esophagus, cryotherapy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - August 31, 2017 Category: Pharmaceuticals Source Type: news

ICR researchers discover use of ibrutinib drug to attack oesophageal cancer cells
Scientists from the UK Institute of Cancer Research (ICR) have identified an existing drug, ibrutinib, which could be effective against oesophageal cancers. (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - August 23, 2017 Category: Pharmaceuticals Source Type: news

In Esophageal Cancer, Women Have Stronger Responses In Esophageal Cancer, Women Have Stronger Responses
Chemoradiotherapy followed by surgery is standard of care for locally advanced esophageal cancer, but how the sexes respond to treatment is not uniform.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - August 23, 2017 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Cancer survival: Current treatment for THIS deadly type works better in women
CANCER treatment tends to be the same for men and women, but a new study on oesophageal cancer has found that treating genders differently may be more effective. (Source: Daily Express - Health)
Source: Daily Express - Health - August 23, 2017 Category: Consumer Health News Source Type: news

Oesophageal cancer breakthrough: New way to attack deadly cells revealed
OESOPHAGEAL cancer - or cancer of the gullet - could be treated with a existing drug in a new way, experts have found. (Source: Daily Express - Health)
Source: Daily Express - Health - August 22, 2017 Category: Consumer Health News Source Type: news

Females Show Better Response to CRT in Esophageal Cancer
Females more often had complete, nearly complete pathologic response to induction tx; less recurrence (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - August 22, 2017 Category: Cancer & Oncology Tags: Gastroenterology, Oncology, Pharmacy, Radiology, Surgery, Journal, Source Type: news